EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Systemic chemotherapy in addition to CRS‐HIPEC for colorectal peritoneal metastases: A critical systematic review on the impact on overall survival

Teun B M van den Heuvel, Robin J Lurvink, Koen P B Rovers, Irene E G van Hellemond, Ignace H J T de Hingh iD

Journal of Surgical Oncology · 2024

DOI: 10.1002/jso.27849 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Teun B M van den Heuvel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Colorectal Neoplasms, Hyperthermic Intraperitoneal Chemotherapy, Cytoreduction Surgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients with resectable colorectal peritoneal metastases, it is unclear whether systemic chemotherapy, in addition to cytoreductive surgery‐hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC), improves overall survival (OS). This systematic review of 12 retrospective studies involving 3721 patients aimed to summarize the available evidence. Contradictory results were found regarding the effectiveness of neoadjuvant, adjuvant, and perioperative systemic therapies on OS, with a high risk of bias. Available evidence remains inconclusive, stressing the need for prospective, randomized trials, like the ongoing Dutch CAIRO6‐trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsColorectal NeoplasmsHyperthermic Intraperitoneal ChemotherapyCytoreduction Surgical ProceduresAntineoplastic Combined Chemotherapy ProtocolsHumansCombined Modality TherapySurvival RateNeoadjuvant TherapyChemotherapy, Adjuvant

Stichwörter der Autor:innen

CRS‐HIPECcolorectal canceroverall survivalperitoneal metastasessystematic reviewsystemic chemotherapy

Autor:innen und Institutionen

  • Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
  • Department of Oncology and Developmental Biology (GROW), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
  • Department of Medical Oncology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
  • Department of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.

ORCID-Profile: Ignace H J T de Hingh

Zitieren

APA

van den Heuvel, T. B. M., Lurvink, R. J., Rovers, K. P. B., van Hellemond, I. E. G., & de Hingh, I. H. J. T. (2024). Systemic chemotherapy in addition to CRS‐HIPEC for colorectal peritoneal metastases: A critical systematic review on the impact on overall survival. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27849

Vancouver

van den Heuvel TBM, Lurvink RJ, Rovers KPB, van Hellemond IEG, de Hingh IHJT. Systemic chemotherapy in addition to CRS‐HIPEC for colorectal peritoneal metastases: A critical systematic review on the impact on overall survival. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27849

BibTeX
@article{vandenHeuvel2024,
  author = {van den Heuvel, Teun B M and Lurvink, Robin J and Rovers, Koen P B and van Hellemond, Irene E G and de Hingh, Ignace H J T},
  title = {Systemic chemotherapy in addition to CRS‐HIPEC for colorectal peritoneal metastases: A critical systematic review on the impact on overall survival},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1002/jso.27849}
}
Kostenlos starten →